Cargando…
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
OBJECTIVES: Early osteoporotic fractures have a great impact on disease progression, the first fracture being a major risk factor for further fractures. Strontium ranelate efficacy against vertebral fractures is presently assessed in a subset of women aged 50–65 years. METHODS: The Spinal Osteoporos...
Autores principales: | Roux, C, Fechtenbaum, J, Kolta, S, Isaia, G, Andia, J B Cannata, Devogelaer, J-P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582331/ https://www.ncbi.nlm.nih.gov/pubmed/18713788 http://dx.doi.org/10.1136/ard.2008.094516 |
Ejemplares similares
-
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
por: Meunier, P. J., et al.
Publicado: (2009) -
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011) -
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010) -
Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
por: Hiligsmann, M., et al.
Publicado: (2013) -
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy
por: Blake, Glen M, et al.
Publicado: (2006)